[1]
A. M. Al-Humaidhi, “A review study of targeting of AAK1 and JAK1/2 using baricitinib in COVID-19 infected human cells”, Al-Kindy Col. Med. J, vol. 16, no. supplement, pp. 9–15, Jul. 2020, doi: 10.47723/kcmj.v16isupplement.176.